1. Home
  2. QNTM vs HOND Comparison

QNTM vs HOND Comparison

Compare QNTM & HOND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNTM
  • HOND
  • Stock Information
  • Founded
  • QNTM 1998
  • HOND 2024
  • Country
  • QNTM Canada
  • HOND United States
  • Employees
  • QNTM N/A
  • HOND N/A
  • Industry
  • QNTM
  • HOND
  • Sector
  • QNTM
  • HOND
  • Exchange
  • QNTM NYSE
  • HOND NYSE
  • Market Cap
  • QNTM 69.3M
  • HOND 334.9M
  • IPO Year
  • QNTM N/A
  • HOND 2024
  • Fundamental
  • Price
  • QNTM $21.02
  • HOND $11.14
  • Analyst Decision
  • QNTM
  • HOND
  • Analyst Count
  • QNTM 0
  • HOND 0
  • Target Price
  • QNTM N/A
  • HOND N/A
  • AVG Volume (30 Days)
  • QNTM 387.2K
  • HOND 328.4K
  • Earning Date
  • QNTM 08-13-2025
  • HOND 01-01-0001
  • Dividend Yield
  • QNTM N/A
  • HOND N/A
  • EPS Growth
  • QNTM N/A
  • HOND N/A
  • EPS
  • QNTM N/A
  • HOND 0.20
  • Revenue
  • QNTM N/A
  • HOND N/A
  • Revenue This Year
  • QNTM N/A
  • HOND N/A
  • Revenue Next Year
  • QNTM N/A
  • HOND N/A
  • P/E Ratio
  • QNTM N/A
  • HOND $53.55
  • Revenue Growth
  • QNTM N/A
  • HOND N/A
  • 52 Week Low
  • QNTM $2.70
  • HOND $9.90
  • 52 Week High
  • QNTM $38.25
  • HOND $12.24
  • Technical
  • Relative Strength Index (RSI)
  • QNTM 54.83
  • HOND N/A
  • Support Level
  • QNTM $15.88
  • HOND N/A
  • Resistance Level
  • QNTM $19.50
  • HOND N/A
  • Average True Range (ATR)
  • QNTM 2.66
  • HOND 0.00
  • MACD
  • QNTM -0.64
  • HOND 0.00
  • Stochastic Oscillator
  • QNTM 39.18
  • HOND 0.00

About QNTM QUANTUM BIOPHARMA LTD

Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.

About HOND HCM II ACQUISITION CORP

HCM II Acquisition Corp is a blank check company.

Share on Social Networks: